Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: Assessment of relapse during a 6-month, multisite, open-label study

Philip G. Janicak, Ziad Nahas, Sarah H. Lisanby, H. Brent Solvason, Shirlene M. Sampson, William M. McDonald, Lauren B. Marangell, Peter Rosenquist, W. Vaughn McCall, James Kimball, John P. O'Reardon, Colleen Loo, Mustafa H. Husain, Andrew Krystal, William Gilmer, Sheila M. Dowd, Mark A. Demitrack, Alan F. Schatzberg

Research output: Contribution to journalReview articlepeer-review

93 Scopus citations

Fingerprint Dive into the research topics of 'Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: Assessment of relapse during a 6-month, multisite, open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences